Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease

被引:95
|
作者
Caminiti, Silvia Paola [1 ,2 ]
Presotto, Luca [2 ]
Baroncini, Damiano [3 ]
Garibotto, Valentina [4 ]
Moresco, Rosa Maria [5 ,6 ]
Gianolli, Luigi [7 ]
Volonte, Maria Antonietta [3 ]
Antonini, Angelo [8 ,9 ]
Perani, Daniela [1 ,2 ,7 ]
机构
[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy
[3] Osped San Raffaele, Dept Neurol, Via Olgettina 60, I-20132 Milan, Italy
[4] Univ Geneva, Geneva Univ Hosp, Dept Med Imaging, Geneva, Switzerland
[5] IBFM CNR, Segrate, Italy
[6] Univ Milano Bicocca, Dept Hlth Sci, Tecnomed Fdn, Monza, Italy
[7] Osped San Raffaele, Nucl Med Unit, Via Olgettina 60, I-20132 Milan, Italy
[8] IRCCS Hosp San Camillo, Parkinsons Dis & Movement Disorders Unit, Via Alberoni 70, I-30126 Venice, Italy
[9] Univ Padua, Dept Neurosci DNS, Via Giustiniani 5, I-35128 Padua, Italy
关键词
Parkinson's disease; Positron emission tomography; Dopamine transporter; Axonal damage; Molecular connectivity; VENTRAL TEGMENTAL AREA; POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; SUBSTANTIA-NIGRA; BRAIN; TRANSPORTER; PET; DISORDERS; PATHOLOGY; NETWORKS;
D O I
10.1016/j.nicl.2017.03.011
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
A progressive loss of dopamine neurons in the substantia nigra (SN) is considered the main feature of idiopathic Parkinson's disease (PD). Recent neuropathological evidence however suggests that the axons of the nigrostriatal dopaminergic system are the earliest target of a-synuclein accumulation in PD, thus the principal site for vulnerability. Whether this applies to in vivo PD, and also to the mesolimbic system has not been investigated yet. We used [C-11]FeCIT PET to measure presynaptic dopamine transporter (DAT) activity in both nigrostriatal and mesolimbic systems, in 36 early PD patients (mean disease duration in months +/- SD 21.8 +/- 10.7) and 14 healthy controls similar for age. We also performed anatomically-driven partial correlation analysis to evaluate possible changes in the connectivity within both the dopamine networks at an early clinical phase. In the nigrostriatal system, we found a severe DAT reduction in the afferents to the dorsal putamen (DPU) (eta(2) = 0.84), whereas the SN was the less affected region (eta(2) = 0.31). DAT activity in the ventral tegmental area (VTA) and the ventral striatum (VST) were also reduced in the patient group, but to a lesser degree (VST eta(2) = 0.71 and VTA eta(2) = 0.31). In the PD patients compared to the controls, there was a marked decrease in dopamine network connectivity between SN and DPU nodes, supporting the significant derangement in the nigrostriatal pathway. These results suggest that neurodegeneration in the dopamine pathways is initially more prominent in the afferent axons and more severe in the nigrostriatal system. Considering PD as a disconnection syndrome starting from the axons, it would justify neuroprotective interventions even if patients have already manifested clinical symptoms.
引用
收藏
页码:734 / 740
页数:7
相关论文
共 50 条
  • [21] Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
    Hou, Lijuan
    Chen, Wei
    Liu, Xiaoli
    Qiao, Decai
    Zhou, Fu-Ming
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [22] Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease
    Lee, Jae Jung
    Oh, Jungsu S.
    Ham, Jee H.
    Lee, Dong H.
    Lee, Injoo
    Sohn, Young H.
    Kim, Jae S.
    Lee, Phil Hyu
    NEUROBIOLOGY OF AGING, 2016, 38 : 197 - 204
  • [23] Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease
    Janis, Kelly L.
    Brennan, Ryan T.
    Drolet, Robert E.
    Behrouz, Bahareh
    Kaufman, Sarah K.
    Lookingland, Keith J.
    Goudreau, John L.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (01) : 97 - 107
  • [24] Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat
    Jack D. Shepard
    David T. Chuang
    Yavin Shaham
    Marisela Morales
    Psychopharmacology, 2006, 185 : 505 - 513
  • [25] Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat
    Shepard, JD
    Chuang, DT
    Shaham, Y
    Morales, M
    PSYCHOPHARMACOLOGY, 2006, 185 (04) : 505 - 513
  • [26] Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease
    Ziegler, Erik
    Rouillard, Maud
    Andre, Elodie
    Coolen, Tim
    Stender, Johan
    Balteau, Evelyne
    Phillips, Christophe
    Garraux, Gaetan
    NEUROIMAGE, 2014, 99 : 498 - 508
  • [27] Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
    Ingrid Morales
    Ricardo Puertas-Avendaño
    Alberto Sanchez
    Adrian Perez-Barreto
    Clara Rodriguez-Sabate
    Manuel Rodriguez
    Translational Neurodegeneration, 10
  • [28] Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease: removing axonal debris
    Morales, Ingrid
    Puertas-Avendano, Ricardo
    Sanchez, Alberto
    Perez-Barreto, Adrian
    Rodriguez-Sabate, Clara
    Rodriguez, Manuel
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [29] Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats
    Zhou, Qingwei
    Chen, Jiajun
    Yi, Shihong
    Lou, Yongwei
    Tang, Weimin
    Liu, Yongmao
    Zhang, Pengguo
    NEURAL REGENERATION RESEARCH, 2012, 7 (27) : 2107 - 2114
  • [30] Gender difference in depletion of presynaptic nigrostriatal dopamine in de novo Parkinson's disease
    Lee, J. J.
    Oh, J. S.
    Ham, J. H.
    Lee, D. H.
    Lee, I.
    Lee, P. H.
    Kim, J. S.
    Sohn, Y. H.
    MOVEMENT DISORDERS, 2015, 30 : S14 - S14